» Articles » PMID: 11040002

Hypertrophic Cardiomyopathy: the Interrelation of Disarray, Fibrosis, and Small Vessel Disease

Overview
Journal Heart
Date 2000 Oct 20
PMID 11040002
Citations 134
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To make a quantitative assessment of the relation between disarray, fibrosis, and small vessel disease in hypertrophic cardiomyopathy.

Design: Detailed macroscopic and histological examination at 19 segments of the left and right ventricle and the left atrial free wall.

Patients: 72 patients with hypertrophic cardiomyopathy who had suffered sudden death or progression to end stage cardiac failure (resulting in death or heart transplantation).

Main Outcome Measures: The presence of scarring, atrial dilatation, and a mitral valve impact lesion were noted, and heart weight, wall thickness, per cent disarray, per cent fibrosis, and per cent small vessel disease quantitated for each heart.

Results: Within an individual heart the magnitude of hypertrophy correlated with the severity of fibrosis (p = 0.006) and disarray (p = 0.0002). Overall, however, total heart weight related weakly but significantly to fibrosis (r = 0.4, p = 0.0001) and small vessel disease (r = 0.3, p = 0.03), but not to disarray. Disarray was greater in hearts with mild left ventricular hypertrophy (maximum wall thickness < 20 mm) and preserved systolic function (60.9 (26)% v 43 (20.4)% respectively, p = 0.02) and hearts without a mitral valve impact lesion (26.3% v 18.9%, p = 0.04), but was uninfluenced by sex. Fibrosis was influenced by sex (7% in male patients and 4% in female, p = 0.04), but not by the presence of an impact lesion. No relation was found between disarray, fibrosis, and small vessel disease.

Conclusions: Myocyte disarray is probably a direct response to functional or structural abnormalities of the mutated sarcomeric protein, while fibrosis and small vessel disease are secondary phenomena unrelated to disarray, but modified by factors such as left ventricular mass, sex, and perhaps local autocrine factors.

Citing Articles

Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.

Llamas-Esperon G, Berrios-Barcenas E, Cossio-Aranda J, Guerra-Lopez A, Magana-Serrano J, Iturralde-Torres P Arch Cardiol Mex. 2025; 94(Supl 4):1-75.

PMID: 39928711 PMC: 11824882. DOI: 10.24875/ACM.M25000098.


Effects of genetic mutations on left ventricular myocardial mechanics and fibrosis patterns in hypertrophic cardiomyopathy.

Kim M, Kim Y, Chung H, Seo J, Park C, Kim T Sci Rep. 2025; 15(1):799.

PMID: 39755839 PMC: 11700167. DOI: 10.1038/s41598-025-85201-0.


Clinical Implications of Pan-Immune-inflammatory Values in Patients with Hypertrophic Cardiomyopathy.

Pay L, Yumurtas A, Dereli S, Cetin T, Kadi H, Cinar T Medeni Med J. 2024; 39(4):254-260.

PMID: 39726388 PMC: 11683294. DOI: 10.4274/MMJ.galenos.2024.96266.


Definitional Challenges in Understanding Hypertrophic Cardiomyopathy.

Federspiel J, Pfeifer J, Ramsthaler F, Reil J, Schmidt P, Sequeira V Diagnostics (Basel). 2024; 14(22).

PMID: 39594199 PMC: 11592529. DOI: 10.3390/diagnostics14222534.


Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy.

Lumish H, Sherrid M, Janssen P, Ferrari G, Hasegawa K, Castillero E J Am Coll Cardiol. 2024; 84(20):1999-2011.

PMID: 39365226 PMC: 11817648. DOI: 10.1016/j.jacc.2024.07.043.


References
1.
Maron B, Ferrans V, Henry W, Clark C, REDWOOD D, Roberts W . Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings. Circulation. 1974; 50(3):436-46. DOI: 10.1161/01.cir.50.3.436. View

2.
TEARE D . Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 1958; 20(1):1-8. PMC: 492780. DOI: 10.1136/hrt.20.1.1. View

3.
Ten Cate F, Roelandt J . Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy. Am Heart J. 1979; 97(6):762-5. DOI: 10.1016/0002-8703(79)90012-7. View

4.
St John Sutton M, Lie J, Anderson K, OBrien P, Frye R . Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis. Br Heart J. 1980; 44(4):433-43. PMC: 482424. DOI: 10.1136/hrt.44.4.433. View

5.
Maron B, Roberts W . Hypertrophic cardiomyopathy and cardiac muscle cell disorganization revisited: relation between the two and significance. Am Heart J. 1981; 102(1):95-110. DOI: 10.1016/0002-8703(81)90419-1. View